Apparatus for optimizing a patient's insulin dosage regimen
Inventors
Assignees
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Publication Number
US-10335546-B2
Publication Date
2019-07-02
Expiration Date
Abstract
An apparatus for optimizing a patient's insulin dosage regimen over time, comprising: at least a first computer-readable memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen and the patient's blood-glucose-level measurements determined at a plurality of times; a processor operatively connected to the at least first computer-readable memory, the processor programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components of the patient's present insulin dosage regimen in order to maintain the patient's future blood-glucose-level measurements within a predefined range; and a display operative to display information corresponding to at least the patient's present insulin dosage regimen.
Core Innovation
The invention relates to an apparatus for improving a patient's insulin dosage regimen. The apparatus includes computer-readable memory and programming instructions, data inputs corresponding to components of the patient's insulin dosage regimen, and a patient's blood-glucose-level measurements determined at a plurality of times within a predefined period of time. A timer monitors the predefined period of time by incrementing based on passage of a separate predetermined increment of time and/or receipt of the blood-glucose-level measurements.
The processor executes the programming instructions to update the insulin dosage regimen displayed to the patient. It performs determinations during the predefined period of time that reflect hypoglycemic event status, including determining a number that represents excessive hypoglycemic events and determining whether an obtained blood-glucose-level measurement reflects a hypoglycemic event or a severe hypoglycemic event.
In response to a severe hypoglycemic event determination or an excessive number of hypoglycemic events during the predefined period of time, the processor reduces at least one component of the insulin dosage regimen. At the end of the predefined period of time, the processor determines whether and by how much to vary at least one component of the insulin dosage regimen from a plurality of the blood-glucose-level measurements in order to maintain the patient's blood-glucose-level measurements within a predefined range, and revised at least one component is communicated to the display.
Claims Coverage
Only one independent claim is provided (apparatus). The inventive features include timed monitoring of a predefined period, event-based reduction of insulin-regimen components for severe and excessive hypoglycemic events, and end-of-period determination of whether and by how much to vary regimen components to maintain glucose within a predefined range, followed by communicating revised regimen information to a display.
Timed monitoring over a predefined period
A timer for monitoring the predefined period of time, the timer being incremented based on at least one of passage of a separate predetermined increment of time or receipt of at least one of the patient's blood-glucose-level measurements.
Severe and excessive hypoglycemic event determinations
Determining a number that represents excessive hypoglycemic events within the predefined period of time, and determining after obtaining at least one blood-glucose-level measurement but before obtaining a subsequent blood-glucose-level measurement whether the obtained blood-glucose-level measurement reflects a hypoglycemic event or a severe hypoglycemic event.
Event-based reduction of regimen components
Reducing at least one of the one or more components in the patient's insulin dosage regimen in response to a determination that the obtained blood-glucose-level measurement represents a severe hypoglycemic event, and reducing at least one of the one or more components in the patient's insulin dosage regimen in response to a determination that the obtained blood-glucose-level measurements results in an excessive number of hypoglycemic events during the predefined period of time.
End-of-period regimen variation to keep glucose within a range
Determining, at the end of the predefined period of time, from a plurality of the data corresponding to the patient's blood-glucose-level measurements whether and by how much to vary at least one of the one or more components in the patient's insulin dosage regimen in order to maintain the patient's blood-glucose-level measurements within a predefined range, and communicating the revised at least one of the one or more components to the display to enable the patient's insulin dosage regimen to be updated on the display.
The provided independent claim covers an apparatus that uses a timer tied to multiple blood-glucose measurements, performs determinations for severe and excessive hypoglycemic events to trigger reductions of insulin dosage regimen components, then determines whether and by how much to vary at least one regimen component to keep glucose within a predefined range, with revised regimen information communicated to a display.
Stated Advantages
Not explicitly described in patent.
Documented Applications
Not explicitly described in patent.
Interested in licensing this patent?